ITGA6 and breast cancer: Recently, using breast cancer patient-derived orthoxenografts (PDXs), Gomez-miragaya et al. [25] have demonstrated that CD49f-positive sub-population exhibits tumour-initiating ability and increased resistance to taxanes.